Arcadia Biosciences Inc Market Cap ($324.99K)

$324.99K USD  · Rank #31230

Market Cap & Net Worth: Arcadia Biosciences Inc (RKDA)

Arcadia Biosciences Inc market cap. Arcadia Biosciences Inc (NASDAQ:RKDA) has a market capitalization of $324.99K ($324.99K) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31230 globally and #6343 in its home market, demonstrating a -2.47% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arcadia Biosciences Inc's stock price $0.16 by its total outstanding shares 2056884 (2.06 Million). Also see RKDA cash generation efficiency for how efficiently the company converts equity into cash flow.

Arcadia Biosciences Inc Market Cap History (2015–2026)

Arcadia Biosciences Inc market cap history from 2015 to 2026. Data shows change from $5.00 Billion to $324.99K (-58.08% CAGR). Check Arcadia Biosciences Inc (RKDA) share price today for real-time trading data and today's change.

Index Memberships

Arcadia Biosciences Inc is a constituent of 1 market index:

Index Total Market Cap Weight (%) Rank by Market Cap
NASDAQ Composite
IXIC
$40.09 Trillion 0.00% #2897 of 3165

Weight: Arcadia Biosciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Arcadia Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Arcadia Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Arcadia Biosciences Inc to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.84x

Arcadia Biosciences Inc's market cap is 0.84 times its annual revenue

Industry average: 0.36x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $1.51 Billion $3.19 Million -$19.62 Million 474.86x N/A
2017 $452.51 Million $4.03 Million -$15.71 Million 112.40x N/A
2018 $260.81 Million $1.46 Million -$13.48 Million 178.15x N/A
2019 $450.87 Million $1.17 Million -$28.80 Million 385.69x N/A
2020 $208.16 Million $8.03 Million -$4.66 Million 25.91x N/A
2021 $85.57 Million $6.78 Million -$14.66 Million 12.62x N/A
2022 $22.30 Million $7.42 Million -$15.38 Million 3.01x N/A
2023 $6.44 Million $4.45 Million -$13.98 Million 1.45x N/A
2024 $12.18 Million $5.04 Million -$7.04 Million 2.41x N/A
2025 $4.07 Million $4.86 Million -$2.34 Million 0.84x N/A

Competitor Companies of RKDA by Market Capitalization

Companies near Arcadia Biosciences Inc in the global market cap rankings as of November 3, 2026. Also see Arcadia Biosciences Inc balance sheet assets for a full breakdown of the balance sheet.

Key companies related to Arcadia Biosciences Inc by market ranking:

  • Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
  • Nestle S.A. (SW:NESN): Ranked #102 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
  • Danone SA (PA:BN): Ranked #541 globally with a market cap of $49.33 Billion USD ( €42.19 Billion EUR).
  • Danone SA (F:BSND): Ranked #674 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#88 Nestlé S.A F:NESM $224.33 Billion €91.60
#102 Nestle S.A. SW:NESN $199.45 Billion CHF84.70
#541 Danone SA PA:BN $49.33 Billion €65.52
#674 Danone SA F:BSND $39.61 Billion €12.40

Market Capitalization of Arcadia Biosciences Inc (2015–2026)

Market capitalization of Arcadia Biosciences Inc from 2015 to today. Between 2015 and today, Arcadia Biosciences Inc's market cap moved from $5.00 Billion to $ 324.99K, with a yearly change of -58.08%.

Year Market Cap Change (%)
2026 $324.99K -92.02%
2025 $4.07 Million -66.55%
2024 $12.18 Million +89.14%
2023 $6.44 Million -71.13%
2022 $22.30 Million -73.94%
2021 $85.57 Million -58.89%
2020 $208.16 Million -53.83%
2019 $450.87 Million +72.87%
2018 $260.81 Million -42.36%
2017 $452.51 Million -70.11%
2016 $1.51 Billion -69.74%
2015 $5.00 Billion --

End of Day Market Cap According to Different Sources

On Nov 2nd, 2026 the market cap of Arcadia Biosciences Inc was reported to be:

Source Market Cap
Yahoo Finance $324.99K USD
MoneyControl $324.99K USD
MarketWatch $324.99K USD
marketcap.company $324.99K USD
Reuters $324.99K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Arcadia Biosciences Inc

NASDAQ:RKDA USA Packaged Foods
Market Cap
$324.99K
Market Cap Rank
#31230 Global
#6343 in USA
Share Price
$0.16
Change (1 day)
-7.33%
52-Week Range
$0.15 - $3.90
All Time High
$3520.00
About

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more